Healio
Healio
an image of a hand in a blue medical glove holding a tube of blood with blood cells as the background

Take Homes in Benign Hematology
ByDavid Statman
Fact checked byMindy Valcarcel, MS

Read more

December 24, 2024
3 min watch
Save

VIDEO: Trial examines hydroxyurea in patients with hemoglobin SC disease

ByDavid Statman
Fact checked byMindy Valcarcel, MS

In this video, Ronak Mistry, DO, discusses the results of a study presented at ASH Annual Meeting that examined the use of hydroxyurea in patients with hemoglobin SC disease.

Mistry, an assistant professor at University of Pennsylvania, highlighted the phase 2 PIVOT study — a Ghanaian trial that treated patients with a medication generally used for sickle cell disease with hemoglobin SS phenotype.

“This is still not ready for the limelight yet. But I think that I was happy to see that we are improving options for patients that have limited options — for patients with hemoglobin SC disease with sickle-cell,” Mistry said.

Reference:

  • Dei-Abdomakoh Y, et al. Abstract 3. Presented at: ASH Annual Meeting and Exposition; Dec. 7-10, 2024; San Diego.
Sources/Disclosures

Collapse
Source:

Healio Interviews

Disclosures: Mistry reports no relevant financial disclosures.

Read more about

sickle cell disease
hemoglobin sc disease
hydroxyurea
 

Related Content